GALE sale of its Zuplenz® (ondansetron) Oral Soluble Film product to Midatech Pharma Plc in a deal valued at up to $29.75 million - The transaction is expected to be completed on or prior to Thursday, December 24, 2015, subject to customary closing conditions.
Rock Solid Development - Strategic Asset Development for a Dominant Future
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.